SEIE - ETF AI Analysis

Top Page

SEI Select International Equity ETF (SEIE)

Rating:64Neutral

Price Target:―

SEIE, the SEI Select International Equity ETF, has a solid overall rating driven mainly by high-quality global leaders like Novartis and AstraZeneca, which show strong financial performance, positive earnings calls, and healthy product pipelines that support long-term growth. Other major holdings such as HSBC, Barclays, and Standard Chartered also add to the fund’s strength with solid financials and strategic initiatives like share buybacks, though some names like ING and Roche face cash flow or valuation concerns that slightly weigh on the rating. A key risk is the fund’s meaningful exposure to large financial and healthcare companies, which could make performance more sensitive to sector-specific shocks.

Positive Factors

Strong Recent Performance

The ETF has shown solid gains so far this year and over the past month, indicating positive recent momentum.

Leading Global Companies in Top Holdings

Several of the largest positions, including major financial, health care, and technology names, have delivered strong year-to-date results that support the fund’s overall performance.

Broad International Diversification

Holdings spread across many developed markets such as Japan, the UK, and several European countries help reduce reliance on any single economy.

Negative Factors

Moderately High Expense Ratio

The fund’s fee level is on the higher side for an ETF, which can gradually reduce net returns for long-term investors.

Financial Sector Sensitivity

Meaningful exposure to financial stocks, including some lagging bank holdings, can make the ETF more vulnerable if that sector weakens.

Limited U.S. Market Exposure

With only a small portion invested in U.S. companies, the fund may miss out when the U.S. market outperforms other regions.

SEIE vs. SPDR S&P 500 ETF (SPY)

AUM1.07B

RegionDeveloped Markets

Expense Ratio0.50%

Beta0.75

IssuerSEI

Inception DateOct 10, 2024

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume76,172

30 Day Avg. Volume92,985

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

39.68

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering339

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SEIE Summary

The SEI Select International Equity ETF (SEIE) is a global stock fund that invests in companies outside the U.S., without tracking a specific index. It spreads money across many countries like Japan, the UK, France, and Germany, and across sectors such as financials, industrials, and health care. Well-known holdings include HSBC, Novartis, ASML, and AstraZeneca. An investor might choose SEIE to diversify beyond U.S. stocks and seek long-term growth from international markets. However, the fund’s value can go up and down with global stock markets and changes in foreign economies and currencies.

How much will it cost me?The SEI Select International Equity ETF (SEIE) has an expense ratio of 0.5%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average because it is actively managed, which typically involves more research and decision-making compared to passively managed funds that track an index.

What would affect this ETF?The SEI Select International Equity ETF (SEIE) could benefit from positive trends in developed markets outside the U.S., such as economic growth or technological advancements, particularly in sectors like financials and healthcare, which have significant weight in the fund. However, challenges like rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact its performance, especially for top holdings like HSBC and Novartis. Diversification across sectors and countries helps mitigate some risks but does not eliminate exposure to global economic uncertainties.

SEIE Top 10 Holdings

SEIE leans heavily into developed markets outside the U.S., with a clear tilt toward European and Japanese blue chips. Financials like HSBC and ING are doing much of the heavy lifting, with their shares steadily rising and helping set the tone for the fund. On the growth side, Murata and ASML have been standout performers, giving the portfolio a strong tech and semiconductor flavor. Health care is more of a mixed bag: Novartis is holding its own, while AstraZeneca and GSK have been losing a bit of steam, modestly dragging on overall returns.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
HSBA	HSBC Holdings	1.91%	$20.38M	£227.13B	58.43%	80 Outperform
ASML	ASML Holding NV	1.53%	$16.32M	€602.01B	142.79%	76 Outperform
6981	Murata Manufacturing Co	1.47%	$15.70M	¥16.54T	255.59%	77 Outperform
GSK	GlaxoSmithKline	1.24%	$13.25M	£78.67B	31.26%	77 Outperform
NOVN	Novartis AG	1.17%	$12.45M	CHF221.88B	25.65%	80 Outperform
INGA	ING GROEP	1.12%	$11.93M	€71.07B	42.31%	61 Neutral
BARC	Barclays	0.98%	$10.41M	£60.73B	48.09%	78 Outperform
AZN	AstraZeneca	0.97%	$10.31M	$282.36B	22.54%	80 Outperform
RHHVF	Roche Holding AG	0.95%	$10.11M	$325.50B	25.62%	73 Outperform
CFR	Compagnie Financiere Richemont SA	0.94%	$10.05M	CHF101.89B	18.95%	78 Outperform

SEIE Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

34.64

Positive

100DMA

34.13

Positive

200DMA

32.53

Positive

Market Momentum

MACD

0.10

Positive

RSI

55.46

Neutral

STOCH

27.23

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SEIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.03, equal to the 50-day MA of 34.64, and equal to the 200-day MA of 32.53, indicating a bullish trend. The MACD of 0.10 indicates Positive momentum. The RSI at 55.46 is Neutral, neither overbought nor oversold. The STOCH value of 27.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SEIE.

SEIE Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
SEIE	―	―	$1.07B	0.50%	64 Neutral
DIHP	―	―	$5.97B	0.27%	67 Neutral
DFIS	―	―	$5.76B	0.39%	58 Neutral
CGIE	―	―	$2.24B	0.54%	65 Neutral
TOUS	―	―	$1.45B	0.50%	64 Neutral
DFSI	―	―	$1.07B	0.24%	64 Neutral

Performance Comparison

SEIE

SEI Select International Equity ETF

35.34

7.06

24.96%

DIHP

Dimensional International High Profitability ETF

―

DFIS

Dimensional International Small Cap ETF

―

CGIE

Capital Group International Equity ETF

―

TOUS

T. Rowe Price International Equity ETF

―

DFSI

Dimensional International Sustainability Core 1 ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents